The number of additional high molecular risk mutations predicts outcome after hematopoietic stem cell transplantation in primary and secondary myelofibrosis.

ABSTRACT:

SUBMITTER: Finazzi MC 

PROVIDER: S-EPMC12540687 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature